Home › Funds › NEXTBio Capital Management LP › VNDA
NEXTBio Capital Management LP position in VNDA
VANDA PHARMACEUTICALS INC · Health Care
NEXTBio Capital Management LP reported holding 100,000 shares of VNDA (VANDA PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$2.0M, representing 0.87% of its reported portfolio and ranking #22 among its reported holdings. NEXTBio Capital Management LP first reported this position in Q3 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How NEXTBio Capital Management LP's VNDA position evolved
NEXTBio Capital Management LP first disclosed a stake in VNDA in Q3 2026 at 100,000 shares (US$2.0M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 100.00K | $1.99M | New |
About VNDA and 13F data
VNDA (VANDA PHARMACEUTICALS INC) is a Health Care company. 33 other funds we track also report a position in VNDA — the largest reported positions include Siren, L.L.C. (US$38.4M), AIGH Capital Management LLC (US$11.0M), Krensavage Asset Management, LLC (US$7.2M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding VNDA
- Siren, L.L.C. 1.93M sh · $38.40M · Q3 2026
- AIGH Capital Management LLC 2.25M sh · $11.05M · Q3 2026
- Krensavage Asset Management, LLC 1.18M sh · $7.22M · Q2 2026
- Vivo Capital, LLC 255.16K sh · $5.09M · Q3 2026
More on NEXTBio Capital Management LP
FAQ
How long has NEXTBio Capital Management LP held VNDA?
NEXTBio Capital Management LP has disclosed VNDA holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is NEXTBio Capital Management LP's current position in VNDA?
As of Q3 2026, NEXTBio Capital Management LP holds 100.00K shares of VNDA (VANDA PHARMACEUTICALS INC), valued at $1.99M, representing 0.87% of its reported portfolio and ranking #22.
Has NEXTBio Capital Management LP been buying or selling VNDA?
In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP newly opened its position in VNDA.
Which other funds hold VNDA?
Other major institutional holders of VNDA include Siren, L.L.C., AIGH Capital Management LLC, Krensavage Asset Management, LLC, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.